Halozyme Therapeutics Inc (HALO): The reason for asking is cause TAK-881 c...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	1
Posts	82
Boards Moderated	0
Alias Born	02/21/2018

stockrafter

Re: stockrafter post# 7429

Monday, 03/20/2023 5:00:26 PM

Monday, March 20, 2023 5:00:26 PM

The reason for asking is cause TAK-881 could be be one of the initial drugs in one of HALO's new fancy HiVol-AI.....

Could have been one of the motivating reason for buy ATRS...

Or not......just snooping while holding.....SR

https://pubmed.ncbi.nlm.nih.gov/36920736/

https://assets-dam.takeda.com/raw/upload/v1675192579/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_tokyo-pdt-day_20191121.pdf

"WE ARE PRIORITIZING NEAR-TERM LATE DEVELOPMENT… RESEARCH / NON-CLINICAL DEVELOPMENT LATE DEVELOPMENT CUVITRU HYQVIA HYQVIA Halozyme Halozyme Wearable Device US - Pediatric PID EU - Pediatric PID HYQVIA HYQVIA - HyHub Halozyme Flextronics Chronic inflammatory demyelinating Delivery Device polyneuropathy (CIDP) HYQVIA CINRYZE Geographic expansion Geographic expansion IMMUNOLOGY CUVITRU GLASSIA Kamada Immunogenicity/ bronchioalveolar Geographic expansion lavage FEIBA Volume reduction HEMATOLOGY 32"